| Source Date | Board Meeting Date | Details |
|
12-Nov-2025
|
14-Nov-2025
|
Quarterly Results
|
|
06-Nov-2025
|
07-Nov-2025
|
Preferential Issue of shares & inter alia, a) to consider and evaluate a proposal issuance of equity shares or any eligible securities or a combination thereof through a preferential issue on a private placement basis, qualified institutional placement, rights issue or through any other permissible mode as may be considered appropriate, subject to such regulatory/ statutory approvals as may be required including the approval of the members of the Company, and to approve such ancillary actions in relation to the above as may be required
|
|
03-Nov-2025
|
06-Nov-2025
|
Preferential Issue of shares & Inter alia, to consider and approve:- a) to consider and evaluate a proposal issuance of equity shares or any eligible securities or a combination thereof through a preferential issue on a private placement basis, qualified institutional placement, rights issue or through any other permissible mode as may be considered appropriate, subject to such regulatory/ statutory approvals as may be required including the approval of the members of the Company, and to approve such ancillary actions in relation to the above as may be required
|
|
01-Sep-2025
|
04-Sep-2025
|
Consolidation of Shares
|
|
04-Aug-2025
|
08-Aug-2025
|
Quarterly Results
|
|
20-May-2025
|
29-May-2025
|
Audited Results
|
|
06-Feb-2025
|
14-Feb-2025
|
Quarterly Results & Inter alia, to consider and approve:- 1) To consider and approve Business Transfer Arrangement (?BTA?) for transfer of the Company?s business under slump sale.
|
|
06-Nov-2024
|
14-Nov-2024
|
Quarterly Results
|
|
07-Aug-2024
|
14-Aug-2024
|
Quarterly Results
|
|
16-May-2024
|
30-May-2024
|
Audited Results
|